Before you sell to, join or invest in Decoy Therapeutics, Inc.
MentionFox check on Decoy Therapeutics, Inc.: only 2 sources on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/decoy-therapeutics-inc-form-d-25000001
Check Decoy Therapeutics, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Decoy Therapeutics, Inc.?
Based on the records MentionFox holds for this company. No flag is not a clearance.
Decoy Therapeutics, Inc. filed an amended Form D with the Securities and Exchange Commission on 2025-04-28.
Decoy Therapeutics, Inc. filed an amended Form D notice of an exempt securities offering with the SEC on April 28, 2025. The filing reports $1.20M sold. Its industry group is Pharmaceuticals. It names Frederick Pierce (Executive Officer, Director), Peter Marschel (Executive Officer, Director), Barbara Hibner (Executive Officer, Director) (SEC Form D/A, April 28, 2025).
Is this your company?
Sell to companies like Decoy Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-04-28 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Decoy Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Decoy Therapeutics, Inc., from the filings we hold.
Pharmaceuticals raises by companies based in Massachusetts, filed within 90 days of this one, largest first.
Get an email when Decoy Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Decoy Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Decoy Therapeutics, Inc. →Get the full cited report on Decoy Therapeutics, Inc.
What the filing shows about Decoy Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Decoy Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Decoy Therapeutics, Inc.'s address as 1 Broadway, 14TH Floor, Cambridge, MA 02142.
Saved here on this device in the meantime, so nothing is lost either way.
Amended on 2025-07-14: the amount sold changed from $1,020,000 to $1,200,000; the number of investors changed from 16 to 20; sales commissions changed from $127,500 to $150,000. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Decoy Therapeutics, Inc. See pricing
Decoy Therapeutics, Inc. is a registered filer with the SEC (CIK 2065438) and has filed since 2025-04-28. 2 filings are on record, the latest on 2025-07-14.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Decoy Therapeutics, Inc.'s Form D of 2025-04-28 names Frederick Pierce, Peter Marschel, Barbara Hibner and 1 more as its officers, directors or promoters.
Its new offerings report $1.02M sold across 1 offering, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
Frederick Pierce is named as Executive Officer and Director on the Form D that Decoy Therapeutics, Inc. filed with the SEC on 28 April 2025, one of 4 people that filing names.
Peter Marschel is named as Executive Officer and Director on the Form D that Decoy Therapeutics, Inc. filed with the SEC on 28 April 2025, one of 4 people that filing names.
Barbara Hibner is named as Executive Officer and Director on the Form D that Decoy Therapeutics, Inc. filed with the SEC on 28 April 2025, one of 4 people that filing names.
Michael Lipp is named as Executive Officer on the Form D that Decoy Therapeutics, Inc. filed with the SEC on 28 April 2025, one of 4 people that filing names.
4 people named on the filing — 4 holding an executive role.
Named as of the 2025-04-28 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Decoy Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Decoy Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Decoy Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Decoy Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Decoy Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Decoy Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/decoy-therapeutics-inc-form-d-25000001